Tuberous Sclerosis Complex Associated with Autism Spectrum Features and Bumetanide as a Pharmacological Indication: A Case Report

Journals Menu

Follow SCIRP

ISSN Print: 2161-7325
ISSN Online: 2161-7333
www.scirp.org/journal/ojpsych
E-mail: ojpsych@scirp.org

"Tuberous Sclerosis Complex Associated with Autism Spectrum Features and Bumetanide as a Pharmacological Indication: A Case Report"
written by Maria Cristina Brió, Mariana Fazzina, Melina Chindi,
published by Open Journal of Psychiatry, Vol.11 No.3, 2021

has been cited by the following article(s):

[1]	Electrophysiological and behavioral evidence for hyper-and hyposensitivity in rare genetic syndromes associated with autism
	Genes, 2022

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top

[1]	Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism Genes, 2022 DOI:10.3390/genes13040671

[2]	Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism Genes, 2022 DOI:10.3390/genes13040671